Evidence map›Paper›PMID 20942424›Full record

ArticleJournal of the American Chemical Society2010

Mechanism of the cobalt oxazoline palladacycle (COP)-catalyzed asymmetric synthesis of allylic esters.

Jeffrey S Cannon, Stefan F Kirsch, Larry E Overman, Helen F Sneddon

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeffrey S CannonDepartment of Chemistry, 1102 Natural Sciences II, University of California, Irvine, California 92697-2025, USA.
Stefan F Kirsch
Larry E Overman
Helen F Sneddon
University of California, Irvine · US

Funding

GENERAL METHODS FOR SYNTHESIS OF BIOACTIVE MATERIALSR01GM030859 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI OVERMAN, LARRY E. · 1985 to 2011
$4.0M
New Methods for the Synthesis of Neurological Agents and Other Heterocyclic MolecR01GM098601 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI OVERMAN, LARRY E. · 2011 to 2014
$1.6M
NIGMS NIH HHS R01 GM030859NIGMS NIH HHS R01 GM098601
6 · The paper itself

Abstract

The catalytic enantioselective S(N)2' displacement of (Z)-allylic trichloroacetimidates catalyzed by the palladium(II) complex [COP-OAc](2) is a broadly useful method for the asymmetric synthesis of chiral branched allylic esters. A variety of experiments aimed at elucidating the nature of the catalytic mechanism and its rate- and enantiodetermining steps are reported. Key findings include the following: (a) the demonstration that a variety of bridged-dipalladium complexes are present and constitute resting states of the COP catalyst (however, monomeric palladium(II) complexes are likely involved in the catalytic cycle); (b) labeling experiments establishing that the reaction proceeds in an overall antarafacial fashion; (c) secondary deuterium kinetic isotope effects that suggest substantial rehybridization at both C1 and C3 in the rate-limiting step; and (d) DFT computational studies (B3-LYP/def2-TZVP) that provide evidence for bidentate substrate-bound intermediates and an anti-oxypalladation/syn-deoxypalladation pathway. These results are consistent with a novel mechanism in which chelation of the imidate nitrogen to form a cationic palladium(II) intermediate activates the alkene for attack by external carboxylate in the enantiodetermining step. Computational modeling of the transition-state structure for the acyloxy palladation step provides a model for enantioinduction.

Indexed as

AlkenesCatalysisCobaltComputer SimulationEstersKineticsModels, MolecularMolecular ConformationOrganometallic CompoundsPalladiumSolutionsStereoisomerismSubstrate SpecificityThermodynamicsAlkenesCobaltEstersOrganometallic CompoundsPalladiumSolutions

Identifiers

PMID20942424
PMCPMC2967776
OpenAlexW1993926366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.